About 160 fluoroquinolones and derivatives were tested for antitrypanosomal
activity in a drug sensitivity assay followed by fluorometric evaluation.
The most active quinolone compounds had IC50 values in the range from 100 t
o 900 ng/ml, while several derivatives were not active at a concentration o
f 100 mug/ml. In a structure activity relationship study, modification of t
he quinolones at position R1, R2, R3 and R8 did not influence trypanocidal
activity. An exchange of the fluor at position 6 may contribute to an incre
ase in activity but does not entirely control it. Pyrrolidine substituents
at position R7 generally were more active than other substituents at this p
osition. Tetracyclic quinolone derivatives were amongst the most active com
pounds with IC50 values in the range of 0.3-8.8 mug/ml. The in vitro cytoto
xicity on HT-29 cells was determined for active compounds with IC50 values
below 1 mug/ml. In addition, six drugs with an IC50 below 1 mug/ml and a se
lectivity index of more than 10 were chosen for in vivo experiments. Dose e
scalation experiments with a maximum dose of 100 mg/kg/bid were performed i
n a mouse model without central nervous system involvement. For unknown rea
sons the in vitro effect of the drugs could not be confirmed in vivo, but t
he class of compound remains of interest for their mode of action, the low
toxicity, pharmacological properties and the availability of a large number
of synthesized compounds.